The Nike Mind shoes have foam nodes on the bottom of the shoe to help activate key pressure points in the brain. Nike Mind pregame mules are $95 while shoes are $145. Whether you're training or in ...

VectorY Therapeutics Receives FDA Fast Track Designation for VTx-002, a First-in-Class Vectorized Antibody Targeting Underlying Disease Biology in ALS ~ Designation enables an enhanced development ...

In a phase 2 trial, intravesical TARA-002 showed a 72% complete response rate at any time among patients with high-grade NMIBC naïve to BCG. The investigational intravesical cell therapy TARA-002 ...

Name: Nike Mind 001 “Light Bone” Colorway: Light Bone/Hyper Crimson/Buff/Chrome SKU: HQ4307-002 MSRP: $130 USD Release Date: January 8, 2026 Where to Buy: Nike Nike is debuting a new paradigm in ...

TARA-002 demonstrates high complete response rates in BCG-naïve NMIBC patients, with 72% achieving CR and 50% maintaining it at 12 months. The treatment involves six weekly bladder instillations, ...

Laboratoires Théa has penned a deal potentially worth up to $280 million to get its hands on Iolyx Therapeutics’ phase 3-ready eye disease drug. The asset in question is ILYX-002, a topical ...

AMSTERDAM & BOSTON--(BUSINESS WIRE)--VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) ...

Vectory Therapeutics BV has obtained IND clearance from the FDA for a phase I/II trial (PIONEER-ALS) of VTX-002, a first-in-class vectorized antibody targeting TDP-43 pathology in amyotrophic lateral ...

The Thor 002 uses a 256 x 192 thermal sensor – its true resolution – and produces a digitally enhanced 512 x 384 image to make thermal maps crisper. Sure, this isn't high-end imaging tech, which you'd ...